Literature DB >> 21587216

Stroke: blood pressure lowering in acute stroke--scant joy from SCAST.

Hisatomi Arima1, John Chalmers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21587216     DOI： 10.1038/nrcardio.2011.61

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  7 in total

1.  The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2).

Authors:  C Delcourt; Y Huang; J Wang; E Heeley; R Lindley; C Stapf; C Tzourio; H Arima; M Parsons; J Sun; B Neal; J Chalmers; C Anderson
Journal:  Int J Stroke       Date:  2010-04       Impact factor: 5.266

2.  Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.

Authors:  Harold P Adams; Gregory del Zoppo; Mark J Alberts; Deepak L Bhatt; Lawrence Brass; Anthony Furlan; Robert L Grubb; Randall T Higashida; Edward C Jauch; Chelsea Kidwell; Patrick D Lyden; Lewis B Morgenstern; Adnan I Qureshi; Robert H Rosenwasser; Phillip A Scott; Eelco F M Wijdicks
Journal:  Stroke       Date:  2007-04-12       Impact factor: 7.914

3.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

4.  Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122).

Authors: 
Journal:  Int J Stroke       Date:  2006-11       Impact factor: 5.266

Review 5.  Relationship between therapeutic changes in blood pressure and outcomes in acute stroke: a metaregression.

Authors:  Chamila M Geeganage; Philip M W Bath
Journal:  Hypertension       Date:  2009-08-03       Impact factor: 10.190

6.  Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?

Authors:  Stephan A Mayer; Stephen M Davis; Brett E Skolnick; Nikolai C Brun; Kamilla Begtrup; Joseph P Broderick; Michael N Diringer; Thorsten Steiner
Journal:  Stroke       Date:  2009-01-15       Impact factor: 7.914

7.  The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.

Authors:  Else Charlotte Sandset; Philip M W Bath; Gudrun Boysen; Dalius Jatuzis; Janika Kõrv; Stephan Lüders; Gordon D Murray; Przemyslaw S Richter; Risto O Roine; Andreas Terént; Vincent Thijs; Eivind Berge
Journal:  Lancet       Date:  2011-02-26       Impact factor: 79.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.